ISSN:1172-8299    

出版商:ADIS    

年代:1994

数据来源: ADIS

摘要:

In an era of increasing resource consciousness on the part of healthcare authorities,1the answer is a resounding‘Yes’.While pharmacoeconomic evaluation is still an evolving science, the economic data produced are becoming increasingly relevant for all players in the healthcare arena. The growing need for such evaluations was a major topic of discussion at a recent IIR conference entitled‘Cost-effective economic evaluations’[London, UK; November 1994].

ISSN:1172-8299    

出版商:ADIS    

年代:1994

数据来源: ADIS

ISSN:1172-8299    

出版商:ADIS    

年代:1994

数据来源: ADIS

ISSN:1172-8299    

出版商:ADIS    

年代:1994

数据来源: ADIS

ISSN:1172-8299    

出版商:ADIS    

年代:1994

数据来源: ADIS

ISSN:1172-8299    

出版商:ADIS    

年代:1994

数据来源: ADIS

摘要:

With the clinical knowledge available to them, clinicians can have a significant impact on the resources used to fund NSAID treatment and on the incidence of adverse reactions. Regrettably, clinical behaviour in the field of NSAID use continues, in many instances, to be inappropriate, damaging to patients and very expensive, according to Professor Alan Maynard, Director of the Centre of Health Economics at York University, UK. He tackled these issues, highlighting the various options available for improving the cost effectiveness of NSAID therapy, at the 10th World Congress of Gastroenterology [Los Angeles, USA; October 1994].

ISSN:1172-8299    

出版商:ADIS    

年代:1994

数据来源: ADIS

ISSN:1172-8299    

出版商:ADIS    

年代:1994

数据来源: ADIS

ISSN:1172-8299    

出版商:ADIS    

年代:1994

数据来源: ADIS

ISSN:1172-8299    

出版商:ADIS    

年代:1994

数据来源: ADIS